Exploring the ability of vocal biomarkers in distinguishing depression from bipolar disorder, schizophrenia, and healthy controls

被引:3
|
作者
Pan, Wei [1 ,2 ,3 ]
Deng, Fusong [4 ]
Wang, Xianbin [1 ,2 ,3 ]
Hang, Bowen [1 ,2 ,3 ]
Zhou, Wenwei [1 ,2 ,3 ]
Zhu, Tingshao [5 ,6 ]
机构
[1] Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China
[2] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China
[3] Key Lab Human Dev & Mental Hlth Hubei Prov, Wuhan, Peoples R China
[4] Wuhan Univ Sci & Technol, Wuhan Wuchang Hosp, Wuchang Hosp, Wuhan, Peoples R China
[5] Chinese Acad Sci, Inst Psychol, Beijing, Peoples R China
[6] Chinese Acad Sci, Inst Psychol, CAS Key Lab Behav Sci, Beijing, Peoples R China
来源
FRONTIERS IN PSYCHIATRY | 2023年 / 14卷
关键词
depression; healthy controls; schizophrenia; bipolar disorder; i-vectors; logistic regression MFCCs; SPEECH EMOTION RECOGNITION; NEGATIVE SYMPTOMS; MATCHING METHODS; FEATURES; PERFORMANCE; EXPRESSION; DISEASES; PROSODY; MODELS;
D O I
10.3389/fpsyt.2023.1079448
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
BackgroundVocal features have been exploited to distinguish depression from healthy controls. While there have been some claims for success, the degree to which changes in vocal features are specific to depression has not been systematically studied. Hence, we examined the performances of vocal features in differentiating depression from bipolar disorder (BD), schizophrenia and healthy controls, as well as pairwise classifications for the three disorders. MethodsWe sampled 32 bipolar disorder patients, 106 depression patients, 114 healthy controls, and 20 schizophrenia patients. We extracted i-vectors from Mel-frequency cepstrum coefficients (MFCCs), and built logistic regression models with ridge regularization and 5-fold cross-validation on the training set, then applied models to the test set. There were seven classification tasks: any disorder versus healthy controls; depression versus healthy controls; BD versus healthy controls; schizophrenia versus healthy controls; depression versus BD; depression versus schizophrenia; BD versus schizophrenia. ResultsThe area under curve (AUC) score for classifying depression and bipolar disorder was 0.5 (F-score = 0.44). For other comparisons, the AUC scores ranged from 0.75 to 0.92, and the F-scores ranged from 0.73 to 0.91. The model performance (AUC) of classifying depression and bipolar disorder was significantly worse than that of classifying bipolar disorder and schizophrenia (corrected p < 0.05). While there were no significant differences in the remaining pairwise comparisons of the 7 classification tasks. ConclusionVocal features showed discriminatory potential in classifying depression and the healthy controls, as well as between depression and other mental disorders. Future research should systematically examine the mechanisms of voice features in distinguishing depression with other mental disorders and develop more sophisticated machine learning models so that voice can assist clinical diagnosis better.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Infection, treatment and immune response in patients with bipolar disorder versus patients with major depression schizophrenia or healthy controls
    Hinze-Selch, D
    BIPOLAR DISORDERS, 2002, 4 : 81 - 83
  • [22] Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia
    Baethge, C
    Baldessarini, RJ
    Freudenthal, K
    Streeruwitz, A
    Bauer, M
    Bschor, T
    BIPOLAR DISORDERS, 2005, 7 (02) : 136 - 145
  • [23] Coping Styles in Twins Discordant for Schizophrenia, Bipolar Disorder, and Depression
    Fortgang, Rebecca G.
    Hultman, Christina M.
    Cannon, Tyrone D.
    CLINICAL PSYCHOLOGICAL SCIENCE, 2016, 4 (02) : 216 - 228
  • [24] Aggression in schizophrenia, bipolar and major depression disorder
    Najafzadeh, Mohammad Javad
    Ghazanfari Pour, Sadra
    Divsalar, Parisa
    JOURNAL OF AGGRESSION CONFLICT AND PEACE RESEARCH, 2023, 15 (04) : 349 - 359
  • [25] Neurological soft signs in bipolar disorder in comparison to healthy controls and schizophrenia: A meta-analysis
    Bora, Emre
    Akgul, Ozge
    Ceylan, Deniz
    Ozerdem, Aysegul
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (11) : 1185 - 1193
  • [26] Brain structure, cognition, and brain age in schizophrenia, bipolar disorder, and healthy controls
    Shahab, Saba
    Mulsant, Benoit H.
    Levesque, Melissa L.
    Calarco, Navona
    Nazeri, Arash
    Wheeler, Anne L.
    Foussias, George
    Rajji, Tarek K.
    Voineskos, Aristotle N.
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (05) : 898 - 906
  • [27] Metabolomic Biomarkers in Mental Disorders: Bipolar Disorder and Schizophrenia
    Quintero, Melissa
    Stanisic, Danijela
    Cruz, Guilherme
    Pontes, Joao G. M.
    Barroso Carneiro Costa, Tassia Brena
    Tasic, Ljubica
    REVIEWS ON BIOMARKER STUDIES IN PSYCHIATRIC AND NEURODEGENERATIVE DISORDERS, 2019, 1118 : 271 - 293
  • [28] Serine enantiomers as diagnostic biomarkers for schizophrenia and bipolar disorder
    Kenji Hashimoto
    European Archives of Psychiatry and Clinical Neuroscience, 2016, 266 : 83 - 85
  • [29] Thought Disorder in Schizophrenia and Bipolar Disorder Probands, Their Relatives, and Nonpsychiatric Controls
    Morgan, Charity J.
    Coleman, Michael J.
    Ulgen, Ayse
    Boling, Lenore
    Cole, Jonathan O.
    Johnson, Frederick V.
    Lerbinger, Jan
    Bodkin, J. Alexander
    Holzman, Philip S.
    Levy, Deborah L.
    SCHIZOPHRENIA BULLETIN, 2017, 43 (03) : 523 - 535
  • [30] Clinical staging in severe mental disorders; bipolar disorder, depression and schizophrenia
    de la Fuente-Tomas, Lorena
    Sanchez-Autet, Monica
    Garcia-Alvarez, Leticia
    Gonzalez-Blanco, Leticia
    Velasco, Angela
    Saiz Martinez, Pilar A.
    Garcia-Portilla, Maria P.
    Bobes, Julio
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2019, 12 (02): : 106 - 115